243.80 USD
▼-6.47-0.53%
盘后 251.64 +0.28%
2026-07-31
市值
$430.82B
市盈率
68.88
EPS
3.54
股息率
2.76%
52 周区间
187.62 – 267.47
成交量
8.03M
Beta
0.28
目标价
270.68
52W 低 187.6252W 高 267.47
价格走势
公司简介
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medi...